Nastech Pharmaceuticals

Saptalis Pharmaceuticals LLC, based in Hauppauge, NY, is a U.S. pharmaceutical company specialized in the development, manufacturing, and commercialization of niche generic and innovative specialty products. Founded in 2015, the company has established a growing portfolio that utilizes ANDA and 505(b)(2) regulatory pathways to provide high-quality, affordable medicines. With state-of-the-art facilities dedicated to producing oral liquid and topical cream products, Saptalis emphasizes cost-effective and time-efficient development processes. The company is committed to improving patients' quality of life through innovative therapeutics, including recently launched products such as Lithium Oral Solution and LIKMEZ™ Metronidazole Oral Suspension. Generated from the website

Gemini Pharmaceuticals Inc, located in Hauppauge, NY, is a worldwide leader in contract manufacturing and product development, specializing in science-based nutritional supplements, private label OTCs, and pet supplements. With FDA and Health Canada registered facilities, Gemini offers a wide range of services including capsule and tablet manufacturing, packaging operations, stability testing, product development, blending operations, functional tablet coating, and analytical testing. Their state-of-the-art R&D facility and ISO 17025 accredited laboratory ensure the highest quality and innovation in their products. Gemini Pharmaceuticals takes pride in their collaborative ideation process, where they transform ideas into tangible products that cater to the unique needs of consumers. They also prioritize sustainability by employing an environmentally conscious approach to material sourcing and waste-stream management throughout their manufacturing process. With a wide breadth of elite quality accreditations, Gemini Pharmaceuticals is committed to bringing pharma into nutrition and providing their customers with unique advantages in the market.Generated from the website

Amneal Pharmaceuticals, located in Hauppauge, NY, is dedicated to challenging conventions in healthcare to make healthy living possible through its broad portfolio of approximately 280 generic and specialty pharmaceuticals. The company is committed to innovation in areas such as oncology and Parkinson's disease, and it actively works to enhance patient access to essential medicines, including first-to-file and first-to-market products. With a strong focus on research and development, Amneal invests significantly in new product development and offers various assistance programs for patients and care partners. Their culture promotes the core values of rising, leading, and succeeding, as they strive to positively impact the lives of patients and their families. Generated from the website